We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DRUGMAKERS ADVISED TO HEW TO TRUTH IN SEC STATEMENTS
DRUGMAKERS ADVISED TO HEW TO TRUTH IN SEC STATEMENTS
April 16, 2004
Legal experts warned drugmakers last week not to "get ahead of the FDA" in making safety and efficacy claims about pipeline products in light of recent changes in the way the agency and the Securities and Exchange Commission (SEC) share confidential information about drug approval procedures.